In some situations, continuing treatment, even at a reduced dose, is the medically appropriate choice
It can clear, lighten, and brighten your skin, boost your energy levels, and strengthen your immune system
Melanotan II is a non-selective pan-melanocortin agonist (MC1R+MC3R+MC4R+MC5R), whereas PT-141 (Bremelanotide) is more selective for MC3R/MC4R with minimal MC1R activity
However, to date, the majority of studies have been performed on small rodent models and the efficacy of BPC 157 is yet to be confirmed in humans
Peptide therapy can support brain-optimization goals in a simple, structured way
Yes, when administered under medical supervision, both treatments are considered very safe and well-tolerated